Login / Signup

Walking a Tightrope: Dosage Modifications and Treatment Outcomes of All-Trans-Retinoic Acid, Arsenic Trioxide, and Daunorubicin for High-Risk Acute Promyelocytic Leukemia.

Madhav DanthalaKrishna Reddy GolamariArun SeshachalamAnupama MikkilineniSitalata ChappidiMahesh Babu MekalaElangovan VidhubalaChinnakali Palanivel
Published in: JCO global oncology (2021)
The study sheds light on the modifications made to recommended dosages of ATRA, ATO, and DNR to optimize outcomes in high-risk APL and reaffirms the importance of ATO use in the front-line setting to achieve durable responses with minimal toxicity.
Keyphrases